{"disease":{"id":"premenopausal-breast-cancer","name":"premenopausal breast cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07106632","title":"Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":3380,"lead_sponsor_name":"UNICANCER","has_results":false},{"nct_id":"NCT05801705","title":"Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03209518","title":"Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in \"Premenopausal Breast Cancer\"","phase":"","overall_status":"COMPLETED","enrollment_count":312,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04997941","title":"Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":238,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04819243","title":"PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":178,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT06458764","title":"Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Candiolo Cancer Institute - IRCCS","has_results":false},{"nct_id":"NCT07127315","title":"Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Helwan University","has_results":false},{"nct_id":"NCT05720260","title":"Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT03407768","title":"Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"University of Saskatchewan","has_results":false},{"nct_id":"NCT02152943","title":"Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT03505736","title":"Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT02990845","title":"Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}